Aes-103
Aes-103-002
Phase 2 small_molecule completed
Quick answer
Aes-103 for Sickle Cell Disease is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Sickle Cell Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed